Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals

Citation
Aw. Lohse et al., Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals, HEPATOLOGY, 29(4), 1999, pp. 1078-1084
Citations number
33
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
HEPATOLOGY
ISSN journal
02709139 → ACNP
Volume
29
Issue
4
Year of publication
1999
Pages
1078 - 1084
Database
ISI
SICI code
0270-9139(199904)29:4<1078:COTOSO>2.0.ZU;2-W
Abstract
Some patients with autoimmune liver disease present with a clinical and/or histological picture showing characteristic findings of both autoimmune hep atitis (AIH) and primary biliary cirrhosis (PBC). Various names, mostly ove rlap syndrome, have been used to describe these cases, which have thus far not been more closely characterized. The aim of this study was the comparis on of 20 patients with overlapping features to representative patients cons idered suffering from typical AIH or typical PBC (20 patients in each group ). We found these patients to indeed show a very mixed picture of both cond itions biochemically, serologically and histologically. However, closer ana lysis suggested that all of these patients were primarily suffering from PB C as all of them had at least either bile duct destruction on histology or anti-M2 positive antimitochondrial antibodies (AMA). We suggest that these PBC patients because of their genetic susceptibility, evidenced by the AIM- characteristic histocompatibility leukocyte antigen (HLA) type B8, DRS, or DR4, developed a more hepatitic picture. Response to immunosuppressive ther apy was excellent, We propose that the name "overlap syndrome" be abandoned for "PBC, hepatitic form." These observations not only have pathophysiolog ical implications, but also suggest that therapy of PBC should be guided by the degree of biochemical and histological hepatic involvement.